Other Stories

Full Video

EMA reviews use of Pfizer vaccines to children aged 5-11 Updated: 2021-10-19 13:41:03 KST

Europe's drug regulator is ramping up COVID-19 inoculations.
The European Medicines Agency says it's currently reviewing use of Pfizer's vaccine for children as young as five.
Last week Pfizer and its German partner BioNtech submitted results from a clinical trial on more than 22-hundred participants.
It showed the vaccine induced a strong immune response in children five to eleven.
The EMA has also given approval to vaccine manufacturing sites for Pfizer in two Italian cities to produce up to 85 million additional doses for the EU.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.